Most Recent Articles about NVS
Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study May 20, 2019 - Adverum's (ADVM) stock gains as the FDA lifts the clinical hold on the second cohort of an initial stage study on lead candidate.
KBC Group NV (KBCSF) CEO Johan Thijs on Q1 2019 Results - Earnings Call Transcript May 17, 2019 - KBC Group NV (OTCPK:KBCSF) Q1 2019 Results Conference Call May 16, 2019 03:30 AM ET Company Participants Kurt De Baenst - Investor Relations Johan Thijs - CEO Rik Scheerlinck - CFO Conference Call Par
KBC Group NV 2019 Q1 - Results - Earnings Call Slides May 17, 2019 - The following slide deck was published by KBC Group NV in conjunction with their 2019 Q1 earnings call.

Related Companies

Name Exchange Price Mkt Cap
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals